To confirm CD4-specific targeting of CD4-Nb1 within the xenograft, we additionally performed ex vivo immunofluorescence of HPB-ALL tumors at 2 and 24 h post injection (Supplementary Figure S11). Here, CD4 is linked to acute lymphoblastic leukemia.